{"id":5017,"date":"2022-02-04T00:00:00","date_gmt":"2022-10-14T16:15:17","guid":{"rendered":"https:\/\/mdbc1.wpengine.com\/courses\/eb-1-mise-a-jour-2020-de-la-pharmacotherapie-pour-le-diabete-de-type-2-chez-ladulte-de-diabete-canada\/"},"modified":"2023-05-02T06:45:27","modified_gmt":"2023-05-02T10:45:27","slug":"eb-1-mise-a-jour-2020-de-la-pharmacotherapie-pour-le-diabete-de-type-2-chez-ladulte-de-diabete-canada","status":"publish","type":"eb_course","link":"https:\/\/www.mdbriefcase.com\/fr\/courses\/eb-1-mise-a-jour-2020-de-la-pharmacotherapie-pour-le-diabete-de-type-2-chez-ladulte-de-diabete-canada\/","title":{"rendered":"Eb 1 : Mise \u00e0 jour 2020 de la pharmacoth\u00e9rapie pour le diab\u00e8te de type 2 chez l\u2019adulte de Diab\u00e8te Canada"},"content":{"rendered":"

Ce vid\u00e9oclip aide la pharmacienne et le pharmacien \u00e0 naviguer parmi les plus r\u00e9centes donn\u00e9es probantes cliniques publi\u00e9es par Diab\u00e8te Canada pour la prise en charge pharmacologique de la glyc\u00e9mie chez les adultes atteints de diab\u00e8te de type 2. L\u2019objectif de ce module est d\u2019aider les pharmaciens \u00e0 comprendre les preuves scientifiques afin de pouvoir les appliquer en toute confiance dans leur pratique et de conseiller efficacement leurs patients.<\/p>\n

\n

Ce programme de formation a fait l\u2019objet d\u2019une bourse \u00e0 vis\u00e9e \u00e9ducative ou d\u2019un soutien en nature de la part de Abbott, Janssen, Novo Nordisk.<\/p>","protected":false},"featured_media":439154,"comment_status":"open","ping_status":"closed","template":"","eb_course_cat":[],"class_list":["post-5017","eb_course","type-eb_course","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"\nEb 1 : Mise \u00e0 jour 2020 de la pharmacoth\u00e9rapie pour le diab\u00e8te de type 2 chez l\u2019adulte de Diab\u00e8te Canada - MDBriefCase<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.mdbriefcase.com\/fr\/cours\/eb-1-mise-a-jour-2020-de-la-pharmacotherapie-pour-le-diabete-de-type-2-chez-ladulte-de-diabete-canada\/\" \/>\n<meta property=\"og:locale\" content=\"fr_CA\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Eb 1 : Mise \u00e0 jour 2020 de la pharmacoth\u00e9rapie pour le diab\u00e8te de type 2 chez l\u2019adulte de Diab\u00e8te Canada - MDBriefCase\" \/>\n<meta property=\"og:description\" content=\"Ce vid\u00e9oclip aide la pharmacienne et le pharmacien \u00e0 naviguer parmi les plus r\u00e9centes donn\u00e9es probantes cliniques publi\u00e9es par Diab\u00e8te Canada pour la prise en charge pharmacologique de la glyc\u00e9mie chez les adultes atteints de diab\u00e8te de type 2. L\u2019objectif de ce module est d\u2019aider les pharmaciens \u00e0 comprendre les preuves scientifiques afin de pouvoir […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.mdbriefcase.com\/fr\/cours\/eb-1-mise-a-jour-2020-de-la-pharmacotherapie-pour-le-diabete-de-type-2-chez-ladulte-de-diabete-canada\/\" \/>\n<meta property=\"og:site_name\" content=\"MDBriefCase\" \/>\n<meta property=\"article:modified_time\" content=\"2023-05-02T10:45:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2022\/02\/Diabetes-Pharmacotherapy-EB1-LP-19.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"600\" \/>\n\t<meta property=\"og:image:height\" content=\"338\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/courses\\\/eb-1-mise-a-jour-2020-de-la-pharmacotherapie-pour-le-diabete-de-type-2-chez-ladulte-de-diabete-canada\\\/\",\"url\":\"https:\\\/\\\/www.mdbriefcase.com\\\/courses\\\/eb-1-mise-a-jour-2020-de-la-pharmacotherapie-pour-le-diabete-de-type-2-chez-ladulte-de-diabete-canada\\\/\",\"name\":\"Eb 1 : Mise \u00e0 jour 2020 de la pharmacoth\u00e9rapie pour le diab\u00e8te de type 2 chez l\u2019adulte de Diab\u00e8te Canada - MDBriefCase\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/courses\\\/eb-1-mise-a-jour-2020-de-la-pharmacotherapie-pour-le-diabete-de-type-2-chez-ladulte-de-diabete-canada\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/courses\\\/eb-1-mise-a-jour-2020-de-la-pharmacotherapie-pour-le-diabete-de-type-2-chez-ladulte-de-diabete-canada\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.mdbriefcase.com\\\/wp-content\\\/uploads\\\/2022\\\/02\\\/Diabetes-Pharmacotherapy-EB1-LP-19.jpg\",\"datePublished\":\"2022-10-14T16:15:17+00:00\",\"dateModified\":\"2023-05-02T10:45:27+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/courses\\\/eb-1-mise-a-jour-2020-de-la-pharmacotherapie-pour-le-diabete-de-type-2-chez-ladulte-de-diabete-canada\\\/#breadcrumb\"},\"inLanguage\":\"fr-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.mdbriefcase.com\\\/courses\\\/eb-1-mise-a-jour-2020-de-la-pharmacotherapie-pour-le-diabete-de-type-2-chez-ladulte-de-diabete-canada\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/courses\\\/eb-1-mise-a-jour-2020-de-la-pharmacotherapie-pour-le-diabete-de-type-2-chez-ladulte-de-diabete-canada\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.mdbriefcase.com\\\/wp-content\\\/uploads\\\/2022\\\/02\\\/Diabetes-Pharmacotherapy-EB1-LP-19.jpg\",\"contentUrl\":\"https:\\\/\\\/www.mdbriefcase.com\\\/wp-content\\\/uploads\\\/2022\\\/02\\\/Diabetes-Pharmacotherapy-EB1-LP-19.jpg\",\"width\":600,\"height\":338},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/courses\\\/eb-1-mise-a-jour-2020-de-la-pharmacotherapie-pour-le-diabete-de-type-2-chez-ladulte-de-diabete-canada\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.mdbriefcase.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Course\",\"item\":\"https:\\\/\\\/www.mdbriefcase.com\\\/courses\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Eb 1 : Mise \u00e0 jour 2020 de la pharmacoth\u00e9rapie pour le diab\u00e8te de type 2 chez l\u2019adulte de Diab\u00e8te Canada\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/#website\",\"url\":\"https:\\\/\\\/www.mdbriefcase.com\\\/\",\"name\":\"MDBriefCase\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.mdbriefcase.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-CA\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/#organization\",\"name\":\"MDBriefCase\",\"url\":\"https:\\\/\\\/www.mdbriefcase.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.mdbriefcase.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/logo.webp\",\"contentUrl\":\"https:\\\/\\\/www.mdbriefcase.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/logo.webp\",\"width\":190,\"height\":36,\"caption\":\"MDBriefCase\"},\"image\":{\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Eb 1 : Mise \u00e0 jour 2020 de la pharmacoth\u00e9rapie pour le diab\u00e8te de type 2 chez l\u2019adulte de Diab\u00e8te Canada - MDBriefCase","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.mdbriefcase.com\/fr\/cours\/eb-1-mise-a-jour-2020-de-la-pharmacotherapie-pour-le-diabete-de-type-2-chez-ladulte-de-diabete-canada\/","og_locale":"fr_CA","og_type":"article","og_title":"Eb 1 : Mise \u00e0 jour 2020 de la pharmacoth\u00e9rapie pour le diab\u00e8te de type 2 chez l\u2019adulte de Diab\u00e8te Canada - MDBriefCase","og_description":"Ce vid\u00e9oclip aide la pharmacienne et le pharmacien \u00e0 naviguer parmi les plus r\u00e9centes donn\u00e9es probantes cliniques publi\u00e9es par Diab\u00e8te Canada pour la prise en charge pharmacologique de la glyc\u00e9mie chez les adultes atteints de diab\u00e8te de type 2. L\u2019objectif de ce module est d\u2019aider les pharmaciens \u00e0 comprendre les preuves scientifiques afin de pouvoir […]","og_url":"https:\/\/www.mdbriefcase.com\/fr\/cours\/eb-1-mise-a-jour-2020-de-la-pharmacotherapie-pour-le-diabete-de-type-2-chez-ladulte-de-diabete-canada\/","og_site_name":"MDBriefCase","article_modified_time":"2023-05-02T10:45:27+00:00","og_image":[{"width":600,"height":338,"url":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2022\/02\/Diabetes-Pharmacotherapy-EB1-LP-19.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.mdbriefcase.com\/courses\/eb-1-mise-a-jour-2020-de-la-pharmacotherapie-pour-le-diabete-de-type-2-chez-ladulte-de-diabete-canada\/","url":"https:\/\/www.mdbriefcase.com\/courses\/eb-1-mise-a-jour-2020-de-la-pharmacotherapie-pour-le-diabete-de-type-2-chez-ladulte-de-diabete-canada\/","name":"Eb 1 : Mise \u00e0 jour 2020 de la pharmacoth\u00e9rapie pour le diab\u00e8te de type 2 chez l\u2019adulte de Diab\u00e8te Canada - MDBriefCase","isPartOf":{"@id":"https:\/\/www.mdbriefcase.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.mdbriefcase.com\/courses\/eb-1-mise-a-jour-2020-de-la-pharmacotherapie-pour-le-diabete-de-type-2-chez-ladulte-de-diabete-canada\/#primaryimage"},"image":{"@id":"https:\/\/www.mdbriefcase.com\/courses\/eb-1-mise-a-jour-2020-de-la-pharmacotherapie-pour-le-diabete-de-type-2-chez-ladulte-de-diabete-canada\/#primaryimage"},"thumbnailUrl":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2022\/02\/Diabetes-Pharmacotherapy-EB1-LP-19.jpg","datePublished":"2022-10-14T16:15:17+00:00","dateModified":"2023-05-02T10:45:27+00:00","breadcrumb":{"@id":"https:\/\/www.mdbriefcase.com\/courses\/eb-1-mise-a-jour-2020-de-la-pharmacotherapie-pour-le-diabete-de-type-2-chez-ladulte-de-diabete-canada\/#breadcrumb"},"inLanguage":"fr-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.mdbriefcase.com\/courses\/eb-1-mise-a-jour-2020-de-la-pharmacotherapie-pour-le-diabete-de-type-2-chez-ladulte-de-diabete-canada\/"]}]},{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.mdbriefcase.com\/courses\/eb-1-mise-a-jour-2020-de-la-pharmacotherapie-pour-le-diabete-de-type-2-chez-ladulte-de-diabete-canada\/#primaryimage","url":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2022\/02\/Diabetes-Pharmacotherapy-EB1-LP-19.jpg","contentUrl":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2022\/02\/Diabetes-Pharmacotherapy-EB1-LP-19.jpg","width":600,"height":338},{"@type":"BreadcrumbList","@id":"https:\/\/www.mdbriefcase.com\/courses\/eb-1-mise-a-jour-2020-de-la-pharmacotherapie-pour-le-diabete-de-type-2-chez-ladulte-de-diabete-canada\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.mdbriefcase.com\/"},{"@type":"ListItem","position":2,"name":"Course","item":"https:\/\/www.mdbriefcase.com\/courses\/"},{"@type":"ListItem","position":3,"name":"Eb 1 : Mise \u00e0 jour 2020 de la pharmacoth\u00e9rapie pour le diab\u00e8te de type 2 chez l\u2019adulte de Diab\u00e8te Canada"}]},{"@type":"WebSite","@id":"https:\/\/www.mdbriefcase.com\/#website","url":"https:\/\/www.mdbriefcase.com\/","name":"MDBriefCase","description":"","publisher":{"@id":"https:\/\/www.mdbriefcase.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.mdbriefcase.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-CA"},{"@type":"Organization","@id":"https:\/\/www.mdbriefcase.com\/#organization","name":"MDBriefCase","url":"https:\/\/www.mdbriefcase.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.mdbriefcase.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp","contentUrl":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp","width":190,"height":36,"caption":"MDBriefCase"},"image":{"@id":"https:\/\/www.mdbriefcase.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/eb_course\/5017","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/eb_course"}],"about":[{"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/types\/eb_course"}],"replies":[{"embeddable":true,"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/comments?post=5017"}],"version-history":[{"count":0,"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/eb_course\/5017\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/media\/439154"}],"wp:attachment":[{"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/media?parent=5017"}],"wp:term":[{"taxonomy":"eb_course_cat","embeddable":true,"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/eb_course_cat?post=5017"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}